{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T23:22:55Z","timestamp":1788650575341,"version":"build-2803163510"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T00:00:00Z","timestamp":1743724800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1-TR-001857"],"award-info":[{"award-number":["UL1-TR-001857"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["KL2TR001856"],"award-info":[{"award-number":["KL2TR001856"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007921","name":"University of Pittsburgh","doi-asserted-by":"publisher","award":["UL1-TR-001857"],"award-info":[{"award-number":["UL1-TR-001857"]}],"id":[{"id":"10.13039\/100007921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"NIMH","doi-asserted-by":"publisher","award":["R01MH113857"],"award-info":[{"award-number":["R01MH113857"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.bbi.2025.04.006","type":"journal-article","created":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T14:20:56Z","timestamp":1743949256000},"page":"170-178","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Lack of relationships between ketamine treatment and peripheral neurotrophic and inflammatory factors in a randomized controlled ketamine trial of major depressive disorder"],"prefix":"10.1016","volume":"128","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1379-743X","authenticated-orcid":false,"given":"Manivel","family":"Rengasamy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Panny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zakary","family":"Hutchinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Marsland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tessa","family":"Kovats","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Griffo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Crystal","family":"Spotts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert H.","family":"Howland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith L.","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay J.","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shabnam","family":"Hossein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca B.","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bbi.2025.04.006_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.bpsgos.2024.100316","article-title":"Experiences of awe mediate ketamine\u2019s antidepressant effects: findings from a randomized controlled trial in treatment-resistant depression","volume":"4","author":"Aepfelbacher","year":"2024","journal-title":"Biol. Psychiatry Global Open Sci."},{"key":"10.1016\/j.bbi.2025.04.006_b0010","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jad.2015.06.033","article-title":"Serum BDNF as a peripheral biomarker of treatment-resistant depression and the rapid antidepressant response: a comparison of ketamine and ECT","volume":"186","author":"Allen","year":"2015","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bbi.2025.04.006_b0015","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cyto.2016.05.010","article-title":"Stability of cytokines, chemokines and soluble activation markers in unprocessed blood stored under different conditions","volume":"84","author":"Aziz","year":"2016","journal-title":"Cytokine"},{"key":"10.1016\/j.bbi.2025.04.006_b0020","unstructured":"Ballard, E.D., R.B. Price, Ketamine for treatment-resistant depression, C.A.Z.S.J. Mathew, S.J. Mathew, and C.A. Zarate Jr, Editors. 2016, Springer."},{"key":"10.1016\/j.bbi.2025.04.006_b0025","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.neuropharm.2015.10.034","article-title":"BDNF\u2013a key transducer of antidepressant effects","volume":"102","author":"Bj\u00f6rkholm","year":"2016","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.bbi.2025.04.006_b0030","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.psyneuen.2010.07.013","article-title":"Determinants of serum brain-derived neurotrophic factor","volume":"36","author":"Bus","year":"2011","journal-title":"Psychoneuroendocrinology"},{"issue":"5","key":"10.1016\/j.bbi.2025.04.006_b0035","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/mp.2014.83","article-title":"Chronic depression is associated with a pronounced decrease in serum brain-derived neurotrophic factor over time","volume":"20","author":"Bus","year":"2015","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbi.2025.04.006_b0040","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.psychres.2018.08.078","article-title":"Rapid inflammation modulation and antidepressant efficacy of a low-dose ketamine infusion in treatment-resistant depression: A randomized, double-blind control study","volume":"269","author":"Chen","year":"2018","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.bbi.2025.04.006_b0045","doi-asserted-by":"crossref","unstructured":"Cohen, J., Statistical power analysis for the behavioral sciences. 2013: Academic press.","DOI":"10.4324\/9780203771587"},{"issue":"7","key":"10.1016\/j.bbi.2025.04.006_b0050","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-027925","article-title":"Systematic review and meta-analysis of the association between peripheral inflammatory cytokines and generalised anxiety disorder","volume":"9","author":"Costello","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.bbi.2025.04.006_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2019.172837","article-title":"Neurotrophic mechanisms underlying the rapid and sustained antidepressant actions of ketamine","volume":"188","author":"Deyama","year":"2020","journal-title":"Pharmacol. Biochem. Behav"},{"key":"10.1016\/j.bbi.2025.04.006_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbi.2019.06.015","article-title":"Markers of central inflammation in major depressive disorder: A systematic review and meta-analysis of studies examining cerebrospinal fluid, positron emission tomography and post-mortem brain tissue","author":"Enache","year":"2019","journal-title":"Brain Behav. Immun."},{"issue":"1\u20132","key":"10.1016\/j.bbi.2025.04.006_b0065","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jad.2008.10.014","article-title":"What happens to patients with treatment-resistant depression? A systematic review of medium to long term outcome studies","volume":"116","author":"Fekadu","year":"2009","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bbi.2025.04.006_b0070","first-page":"1","article-title":"What does plasma CRP tell us about peripheral and central inflammation in depression?","author":"Felger","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbi.2025.04.006_b0075","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jad.2024.12.097","article-title":"The association between cytokines and cognitive function in patients with major depressive disorder and controls","volume":"373","author":"Fromme","year":"2025","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bbi.2025.04.006_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.113935","article-title":"Molecular mechanisms of the rapid-acting and long-lasting antidepressant actions of (R)-ketamine","volume":"177","author":"Hashimoto","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbi.2025.04.006_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2024.107192","article-title":"Dynamic interplay of cortisol and BDNF in males under acute and chronic psychosocial stress\u2013A randomized controlled study","volume":"170","author":"Herhaus","year":"2024","journal-title":"Psychoneuroendocrinology"},{"issue":"10159","key":"10.1016\/j.bbi.2025.04.006_b0090","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","author":"James","year":"2018","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.bbi.2025.04.006_b0095","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1600-065X.2012.01151.x","article-title":"The inflammation highway: metabolism accelerates inflammatory traffic in obesity","volume":"249","author":"Johnson","year":"2012","journal-title":"Immunol. Rev."},{"issue":"3","key":"10.1016\/j.bbi.2025.04.006_b0100","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1213\/00000539-199909000-00024","article-title":"Ketamine suppresses proinflammatory cytokine production in human whole blood in vitro","volume":"89","author":"Kawasaki","year":"1999","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.bbi.2025.04.006_b0105","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3389\/fpsyg.2013.00513","article-title":"Simpson's paradox in psychological science: a practical guide","volume":"4","author":"Kievit","year":"2013","journal-title":"Front. Psychol."},{"issue":"3","key":"10.1016\/j.bbi.2025.04.006_b0110","doi-asserted-by":"crossref","first-page":"e1065","DOI":"10.1038\/tp.2017.31","article-title":"Altered peripheral immune profiles in treatment-resistant depression: response to ketamine and prediction of treatment outcome","volume":"7","author":"Kiraly","year":"2017","journal-title":"Transl Psychiatry"},{"issue":"1","key":"10.1016\/j.bbi.2025.04.006_b0115","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41386-023-01629-w","article-title":"Ketamine and rapid antidepressant action: new treatments and novel synaptic signaling mechanisms","volume":"49","author":"Krystal","year":"2024","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbi.2025.04.006_b0120","first-page":"139","article-title":"Effects of ketamine on levels of inflammatory cytokines IL-6, IL-1\u03b2, and TNF-\u03b1 in the hippocampus of mice following acute or chronic administration","volume":"8","author":"Li","year":"2017","journal-title":"Front. Pharmacol."},{"issue":"10","key":"10.1016\/j.bbi.2025.04.006_b0125","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1038\/s41386-019-0391-y","article-title":"Acute psychosocial stress increases serum BDNF levels: an antagonistic relation to cortisol but no group differences after mental training","volume":"44","author":"Linz","year":"2019","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.bbi.2025.04.006_b0130","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/brain\/awae269","article-title":"Blood inflammation relates to neuroinflammation and survival in frontotemporal lobar degeneration","volume":"148","author":"Malpetti","year":"2025","journal-title":"Brain"},{"key":"10.1016\/j.bbi.2025.04.006_b0135","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.jad.2020.09.007","article-title":"A systematic review and meta-analysis of the efficacy of intravenous ketamine infusion for treatment resistant depression: January 2009\u2013January 2019","volume":"277","author":"Marcantoni","year":"2020","journal-title":"J. Affect. Disord."},{"issue":"9","key":"10.1016\/j.bbi.2025.04.006_b0140","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1038\/s41380-022-01652-1","article-title":"Blood-based biomarkers of antidepressant response to ketamine and esketamine: A systematic review and meta-analysis","volume":"27","author":"Medeiros","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbi.2025.04.006_b0145","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.bbi.2025.04.006_b0150","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1469-185X.2007.00027.x","article-title":"Effect size, confidence interval and statistical significance: a practical guide for biologists","volume":"82","author":"Nakagawa","year":"2007","journal-title":"Biol. Rev."},{"key":"10.1016\/j.bbi.2025.04.006_b0155","article-title":"Targeting inflammation in depression: Ketamine as an anti-inflammatory antidepressant in psychiatric emergency","volume":"18","author":"Nikkheslat","year":"2021","journal-title":"Brain, Behavior, Immun.-Health"},{"issue":"23","key":"10.1016\/j.bbi.2025.04.006_b0160","doi-asserted-by":"crossref","first-page":"13098","DOI":"10.3390\/ijms252313098","article-title":"Variations in BDNF and their role in the neurotrophic antidepressant mechanisms of ketamine and esketamine: a review","volume":"25","author":"Pardossi","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbi.2025.04.006_b0165","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jpsychires.2016.09.025","article-title":"Change in cytokine levels is not associated with rapid antidepressant response to ketamine in treatment-resistant depression","volume":"84","author":"Park","year":"2017","journal-title":"J. Psychiatr. Res."},{"issue":"5","key":"10.1016\/j.bbi.2025.04.006_b0170","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1080\/07420520802387773","article-title":"Diurnal variation of plasma brain\u2010derived neurotrophic factor (BDNF) in humans: an analysis of sex differences","volume":"25","author":"Piccinni","year":"2008","journal-title":"Chronobiol. Int."},{"issue":"12","key":"10.1016\/j.bbi.2025.04.006_b0175","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1176\/appi.ajp.20220216","article-title":"A novel, brief, fully automated intervention to extend the antidepressant effect of a single ketamine infusion: a randomized clinical trial","volume":"179","author":"Price","year":"2022","journal-title":"Am. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.bbi.2025.04.006_b0180","doi-asserted-by":"crossref","first-page":"e2312434","DOI":"10.1001\/jamanetworkopen.2023.12434","article-title":"One-year outcomes following intravenous ketamine plus digital training among patients with treatment-resistant depression: a secondary analysis of a randomized clinical trial","volume":"6","author":"Price","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.bbi.2025.04.006_b0185","first-page":"1","article-title":"Ketamine\u2019s mechanism of action with an emphasis on neuroimmune regulation: can the complement system complement ketamine\u2019s antidepressant effects?","author":"Quintanilla","year":"2024","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbi.2025.04.006_b0190","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.bbi.2020.09.004","article-title":"Longitudinal relationships of cytokines, depression and anhedonia in depressed adolescents","volume":"91","author":"Rengasamy","year":"2021","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2025.04.006_b0195","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1038\/s41386-022-01341-1","article-title":"Does the moderator matter? Identification of multiple moderators of the association between peripheral inflammatory markers and depression severity in a large racially diverse community cohort","volume":"47","author":"Rengasamy","year":"2022","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.bbi.2025.04.006_b0200","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.bpsgos.2021.06.009","article-title":"Cytokine and reward circuitry relationships in treatment-resistant depression","volume":"2","author":"Rengasamy","year":"2022","journal-title":"Biol. Psychiatry Global Open Sci."},{"key":"10.1016\/j.bbi.2025.04.006_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104902","article-title":"Neural connectivity moderators and mechanisms of ketamine treatment among treatment-resistant depressed patients: a randomized controlled trial","volume":"99","author":"Rengasamy","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.bbi.2025.04.006_b0210","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/1061274","article-title":"Antidepressant effect of ketamine on inflammation-mediated cytokine dysregulation in adults with treatment-resistant depression: rapid systematic review","volume":"2022","author":"Sukhram","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.bbi.2025.04.006_b0215","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3389\/fnint.2013.00055","article-title":"Brain-Derived Neurotrophic Factor (BDNF) protein levels in anxiety disorders: systematic review and meta-regression analysis","volume":"7","author":"Suliman","year":"2013","journal-title":"Front. Integr. Neurosci."},{"key":"10.1016\/j.bbi.2025.04.006_b0220","first-page":"1","article-title":"Association between TNF-\u03b1 & IL-6 level changes and remission from depression with duloxetine treatment","author":"Suzuki","year":"2024","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.bbi.2025.04.006_b0225","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3389\/fpsyt.2018.00471","article-title":"Dynamic effects of early adolescent stress on depressive-like behaviors and expression of cytokines and JMJD3 in the prefrontal cortex and hippocampus of rats","volume":"9","author":"Wang","year":"2018","journal-title":"Front. Psych."},{"issue":"4","key":"10.1016\/j.bbi.2025.04.006_b0230","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.3892\/etm.2013.930","article-title":"Ketamine exerts antidepressant effects and reduces IL-1\u03b2 and IL-6 levels in rat prefrontal cortex and hippocampus","volume":"5","author":"Yang","year":"2013","journal-title":"Exp. Ther. Med."},{"issue":"8","key":"10.1016\/j.bbi.2025.04.006_b0235","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1037\/abn0000716","article-title":"Increased inflammation predicts nine-year change in major depressive disorder diagnostic status","volume":"130","author":"Zainal","year":"2021","journal-title":"J. Abnorm. Psychol."},{"issue":"1","key":"10.1016\/j.bbi.2025.04.006_b0240","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/s41398-020-00933-z","article-title":"Alterations of multiple peripheral inflammatory cytokine levels after repeated ketamine infusions in major depressive disorder","volume":"10","author":"Zhan","year":"2020","journal-title":"Transl. Psychiatry"},{"issue":"4","key":"10.1016\/j.bbi.2025.04.006_b0245","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.2174\/1570159X20666220927085706","article-title":"Baseline plasma BDNF levelsare associated with antianhedonic effects of repeated-dose intravenous ketamine in major depressive disorder","volume":"21","author":"Zheng","year":"2023","journal-title":"Curr. Neuropharmacol."},{"issue":"1","key":"10.1016\/j.bbi.2025.04.006_b0250","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s12974-021-02245-5","article-title":"Plasma inflammatory cytokines and treatment-resistant depression with comorbid pain: improvement by ketamine","volume":"18","author":"Zhou","year":"2021","journal-title":"J. Neuroinflammation"}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159125001308?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159125001308?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T04:11:49Z","timestamp":1778040709000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159125001308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":50,"alternative-id":["S0889159125001308"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2025.04.006","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lack of relationships between ketamine treatment and peripheral neurotrophic and inflammatory factors in a randomized controlled ketamine trial of major depressive disorder","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2025.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}